Mechanism of neutralization of influenza virus infectivity by antibodies.

We have determined the mechanism of neutralization of influenza virus infectivity by three antihemagglutinin monoclonal antibodies, the structures of which we have analyzed before as complexes with hemagglutinin. The antibodies differ in their sites of interaction with hemagglutinin and in their abilities to interfere in vitro with its two functions of receptor binding and membrane fusion. We demonstrate that despite these differences all three antibodies neutralize infectivity by preventing virus from binding to cells. Neutralization occurs at an average of one antibody bound per four hemagglutinins, a ratio sufficient to prevent the simultaneous receptor binding of hemagglutinins that is necessary to attach virus to cells.

[1]  J. Skehel,et al.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. , 1987, Annual review of biochemistry.

[2]  J. E. Mellema,et al.  Structure and composition of influenza virus. A small-angle neutron scattering study. , 1985, Journal of molecular biology.

[3]  G M Whitesides,et al.  Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. , 1989, Biochemistry.

[4]  J. Skehel,et al.  Crystalline antigen from the influenza virus envelope. , 1972, Nature: New biology.

[5]  J. Skehel,et al.  An antibody that prevents the hemagglutinin low pH fusogenic transition. , 2002, Virology.

[6]  J. Stephenson,et al.  High and low efficiency neutralization epitopes on the haemagglutinin of type A influenza virus. , 1997, The Journal of general virology.

[7]  J. Skehel,et al.  Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion. , 1983, The Journal of general virology.

[8]  Pascal Rigolet,et al.  Structure of influenza virus haemagglutinin complexed with a neutralizing antibody , 1995, Nature.

[9]  K. Mozdzanowska,et al.  Role of the B‐cell response in recovery of mice from primary influenza virus infection , 1997, Immunological reviews.

[10]  A. Nisalak,et al.  Antibodies that block virus attachment to vero cells are a major component of the human neutralizing antibody response against dengue virus type 2 , 1995, Journal of medical virology.

[11]  Q. Sattentau,et al.  Mechanisms of virus neutralization by antibody. , 2001, Current topics in microbiology and immunology.

[12]  R. Ruigrok,et al.  Mechanisms of rabies virus neutralization. , 1993, Virology.

[13]  I. Wilson,et al.  A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Q. Sattentau,et al.  Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line–adapted HIV-1 Neutralization , 1997, The Journal of experimental medicine.

[15]  Crystallization and preliminary X‐ray diffraction studies of complexes between an influenza hemagglutinin and fab fragments of two different monoclonal antibodies , 1995, Proteins.

[16]  D. Burton,et al.  The antiviral activity of antibodies in vitro and in vivo , 2001, Advances in Immunology.

[17]  Damien Fleury,et al.  A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site , 1999, Nature Structural Biology.

[18]  W. Hunter,et al.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.

[19]  T S Baker,et al.  Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody , 1993, Journal of virology.

[20]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[21]  N. Dimmock,et al.  Update on the neutralisation of animal viruses , 1995 .

[22]  K. Mozdzanowska,et al.  Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice , 1995, Journal of virology.

[23]  J. Skehel,et al.  A neutralizing antibody Fab-influenza haemagglutinin complex with an unprecedented 2:1 stoichiometry: characterization and crystallization. , 2000, Acta crystallographica. Section D, Biological crystallography.

[24]  N. Dimmock,et al.  Quantitative relationships between an influenza virus and neutralizing antibody. , 1987, Virology.

[25]  J. Skehel,et al.  The receptor‐binding and membrane‐fusion properties of influenza virus variants selected using anti‐haemagglutinin monoclonal antibodies. , 1987, The EMBO journal.

[26]  J. Tomassini,et al.  Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments , 1989, Journal of virology.

[27]  J. Moore,et al.  Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1 , 1996, Journal of virology.

[28]  G. Appleyard,et al.  Plaque formation by influenza viruses in the presence of trypsin. , 1974, The Journal of general virology.

[29]  J. Skehel,et al.  Refined three-dimensional structure of the Fab fragment of a murine IgGl,lambda antibody. , 1994, Acta crystallographica. Section D, Biological crystallography.